Tartarone A - Search Results

1

The cardiovascular risk of gonadotropin releasing hormone agonists in men with prostate cancer: an unresolved controversy.

Conteduca V, Di Lorenzo G, Tartarone A, Aieta M. Conteduca V, et al. Among authors: tartarone a. Crit Rev Oncol Hematol. 2013 Apr;86(1):42-51. doi: 10.1016/j.critrevonc.2012.09.008. Epub 2012 Oct 23. Crit Rev Oncol Hematol. 2013. PMID: 23092636 Review.

2

[High-dose chemotherapy of metastatic breast carcinoma].

Tartarone A, Aieta M, Morritti MG, Palomba G, Romano MP, Lelli G. Tartarone A, et al. Clin Ter. 1998 May-Jun;149(3):227-30. Clin Ter. 1998. PMID: 9842107 Review. Italian.

3

Salvage treatment with epirubicin and/or paclitaxel in metastatic breast cancer patients relapsed after high-dose chemotherapy with peripheral blood progenitor cells.

Tartarone A, Sirotovà Z, Aieta M, Lelli G. Tartarone A, et al. Tumori. 2001 May-Jun;87(3):134-7. doi: 10.1177/030089160108700305. Tumori. 2001. PMID: 11504366 Clinical Trial.

4

Role and limits of salvage chemotherapy in breast cancer patients treated with high-dose chemotherapy.

Sirotovà Z, Tartarone A, Aieta M, Morelli F, Toma SS. Sirotovà Z, et al. Among authors: tartarone a. Ann Oncol. 2003 Dec;14(12):1794-5. doi: 10.1093/annonc/mdg485. Ann Oncol. 2003. PMID: 14630689 Free article. No abstract available.

5

Treatment of performance status 2 patients with advanced non-small-cell lung cancer: what we know and what we don't know.

Tartarone A, Aieta M. Tartarone A, et al. Future Oncol. 2009 Aug;5(6):837-41. doi: 10.2217/fon.09.61. Future Oncol. 2009. PMID: 19663733 Review.

6

The clinical impact of a cardiologic follow-up in breast cancer survivors: an observational study.

Gallucci G, Coccaro M, Storto G, Lapadula L, Tartarone A, Nappi A, Cammarota A, Buonerba C, Di Lorenzo G, Fusco V, Aieta M. Gallucci G, et al. Among authors: tartarone a. Int J Immunopathol Pharmacol. 2010 Oct-Dec;23(4):1221-7. doi: 10.1177/039463201002300426. Int J Immunopathol Pharmacol. 2010. PMID: 21244771 Free article.

7

Evaluation of molecular prognostic and predictive factors: an important step towards personalised treatment in non small cell lung cancer.

Tartarone A, Lerose R, Gallucci G, Ardito R, Aieta M. Tartarone A, et al. Med Oncol. 2012 Sep;29(3):1599-605. doi: 10.1007/s12032-011-9992-y. Epub 2011 Jun 2. Med Oncol. 2012. PMID: 21633836 Review.

8

Off-label use of anti-cancer drugs between clinical practice and research: the Italian experience.

Lerose R, Musto P, Aieta M, Papa C, Tartarone A. Lerose R, et al. Among authors: tartarone a. Eur J Clin Pharmacol. 2012 May;68(5):505-12. doi: 10.1007/s00228-011-1173-6. Epub 2011 Dec 14. Eur J Clin Pharmacol. 2012. PMID: 22166932 Review.

9

Anal metastasis from breast cancer: a case report and review of the literature.

Bochicchio A, Tartarone A, Ignomirelli O, Latorre G, Cangiano R, Gallucci G, Coccaro M, Feudale E, Aieta M. Bochicchio A, et al. Among authors: tartarone a. Future Oncol. 2012 Mar;8(3):333-6. doi: 10.2217/fon.12.9. Future Oncol. 2012. PMID: 22409468 Review.

10

Everolimus in HR-positive advanced breast cancer.

Tartarone A, Lerose R, Aieta M. Tartarone A, et al. N Engl J Med. 2012 May 3;366(18):1739; author reply 1739-40. doi: 10.1056/NEJMc1202719. N Engl J Med. 2012. PMID: 22551140 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters